Alamar Biosciences affiliate proposes $8.56M share sale

The notice lists 69,392,766 shares of Alamar common stock outstanding.

Rhea-AI Filing Summary

Alamar Biosciences, Inc. (ALMR) reported a proposed sale by affiliate Qiming Venture Partners VIII Investments, LLC of 363,729 common shares, with an aggregate market value of $8,555,000 and an approximate sale date of October 14, 2026. J.P. Morgan Securities LLC is listed as broker for the proposed transaction.

Key Figures

Common shares proposed for sale: 363,729 shares Aggregate market value: $8,555,000 Common shares acquired: 1,605,645 shares +1 more

4 metrics

Common shares proposed for sale 363,729 shares Approximate sale date: October 14, 2026

Aggregate market value $8,555,000 Proposed sale

Common shares acquired 1,605,645 shares Acquired March 8, 2024

Shares outstanding 69,392,766 shares Number reported in the notice

Key Terms

Rule 144, affiliate, par value, Series C preferred shares

4 terms

Rule 144 regulatory

"sales required by paragraph (e) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

affiliate regulatory

"Affiliate"

par value financial

"par value $0.0001 per share"

Par value is the fixed amount printed on a bond or stock that represents its original value when issued. It’s like the face value of a coin or bill—what the issuer promises to pay back or the starting price of a stock—though it often doesn’t change with market prices. It matters because it helps determine certain financial details, like how much the company will pay back at maturity.

Series C preferred shares financial

"Private investment in Series C preferred shares"

Series C preferred shares are a specific class of stock issued in a later-stage funding round that gives holders priority over common shareholders for dividend payments and for getting money back if the company is sold or liquidated. Think of them like a reserved lane on a highway: they typically carry negotiated protections — such as priority payouts, defined payout terms, and the option to convert into common shares — which change the risk and potential return compared with ordinary stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many ALMR shares does Qiming Venture Partners VIII Investments, LLC propose to sell?

Qiming Venture Partners VIII Investments, LLC proposed to sell 363,729 common shares, with an aggregate market value of $8,555,000 and an approximate sale date of October 14, 2026. J.P. Morgan Securities LLC is listed as broker.

How did Qiming Venture Partners VIII Investments, LLC acquire the ALMR shares?

The notice lists 1,605,645 common shares acquired on March 8, 2024. The acquisition was through a private investment in Series C preferred shares, which automatically converted into common stock upon the IPO.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/14/2026 - 08:23 PM EDT Accepted by SEC EDGAR 10/14/2026 - 08:23 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002129618
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Alamar Biosciences, Inc.
SEC File Number	001-43235
Address of Issuer	47071 BAYSIDE PARKWAY FREMONT CALIFORNIA 94538
Phone	510-626-9888
Name of Person for Whose Account the Securities are To Be Sold	Qiming Venture Partners VIII Investments, LLC
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common stock, par value $0.0001 per share	J.P. Morgan Securities LLC 270 Park Avenue New York NY 10117	363729	8555000.00	69392766	10/14/2026	Nasdaq Stock Market

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common stock	03/08/2024	Private investment in Series C preferred shares, automatically converted into common stock upon IPO	Issuer			1605645	03/07/2024	Check

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	10/14/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Ho Man Lam
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)